Boc-4-(naphthalen-1-yl)-piperidine-4-carboxylic acid, 99.0%, 5g

2-[1-(Ethanesulfonyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]azetidin-3-yl]acetonitrile, 97%, 5g

tert-Butyl 4-iodopicolinate, 95%, 250mg

Aghi per iniezione, 60 mm, 1,00 mm, 12 pezzi

(R)-1-Benzyl-pyrrolidin-3-ol, 95.0%, 1g

tert-Butyl 2-methylaziridine-1-carboxylate, 95.0%, 5g

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one, 95.0%, 1g

2-(tert-Butyl)isonicotinic acid, 95.0%, 1g

Pentafluorophenypropylltrimethoxysilane, 1g

NOTOGINSENOSIDE R1, 98%, 5g

2-amino-9-[(2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one, 98%, 100mg

2,3-Bis(4-bromophenyl)-2-butenedinitrile>98.0%(GC)5g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 5g